Skip to main content
S 3466 114th Congress Senate Health

Accelerating New Pharmaceutical Competition Act

Introduced: September 29, 2016 Introduced by: Paul, Rand Republican · Kentucky See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 29, 2016
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 29, 2016
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Accelerating New Pharmaceutical Competition Act

This bill amends the Federal Food, Drug, and Cosmetic Act to permit brand name drug applications to rely upon investigations conducted in certain foreign countries if the drug has been approved in the foreign country where the investigations were conducted. The Food and Drug Administration (FDA) has 90 days to act on these applications.

The bill revises a provision regarding the effective date of the approval of a generic drug that is subject to a patent infringement action.

The FDA must prioritize the review of, and act within 150 days on, generic drug applications or supplements to generic drug applications for drugs: (1) for which there is a shortage, or (2) that have not been recently introduced to the market by more than one manufacturer and for which tentative approval has not been granted to more than two applications.
What's happening now September 29, 2016

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3466: Accelerating New Pharmaceutical Competition Act. 114th Congress. Open America. https://openamerica.io/bill/114-S-3466/
MLA
"S. 3466: Accelerating New Pharmaceutical Competition Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-S-3466/.
Bluebook (legal)
S. 3466, 114th Cong. (2026), https://openamerica.io/bill/114-S-3466/.
Markdown link
[S. 3466: Accelerating New Pharmaceutical Competition Act](https://openamerica.io/bill/114-S-3466/)
Report a problem